Chartwell Investment Partners, LLC Ionis Pharmaceuticals Inc Transaction History
Chartwell Investment Partners, LLC
- $2.89 Billion
- Q1 2024
A detailed history of Chartwell Investment Partners, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Chartwell Investment Partners, LLC holds 11,756 shares of IONS stock, worth $555,353. This represents 0.02% of its overall portfolio holdings.
Number of Shares
11,756
Previous 12,982
9.44%
Holding current value
$555,353
Previous $657,000
22.37%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding IONS
# of Institutions
398Shares Held
122MCall Options Held
854KPut Options Held
464K-
Vanguard Group Inc Valley Forge, PA13.4MShares$634 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD13.3MShares$629 Million0.35% of portfolio
-
Black Rock Inc. New York, NY9.77MShares$462 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.3MShares$392 Million5.64% of portfolio
-
Wellington Management Group LLP Boston, MA5.7MShares$269 Million0.04% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $6.71B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...